Editorial

Fungal Disease Was Left Out of the AMR Fight

Pharmacists are becoming the front door for cardiometabolic care. Policy is still treating them like the back office

Dementia prevention has a cardiometabolic blind spot

BRCA Care Cannot Start at Diagnosis

The Money Is Moving Into Cancer Screening. The Evidence Still Has to Catch Up.

Huntington’s Needs More Than a Better Curve

Duchenne’s Accelerated Approval Faces Its Test

The Screwworm Border Did Not Hold. Now Mexico and the U.S. Are Betting on Flies.

New nicotine products could become the next major cardiovascular policy failure
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
